Salk Institute researchers have pinpointed a crucial protein, Med14, that acts as a molecular bridge connecting GLP-1 agonist drugs to…
Read More

Salk Institute researchers have pinpointed a crucial protein, Med14, that acts as a molecular bridge connecting GLP-1 agonist drugs to…
Read More
Researchers at the Peter Doherty Institute for Infection and Immunity in Australia have developed a portable, point-of-care diagnostic tool capable…
Read More
The rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally transformed the landscape of metabolic medicine, offering unprecedented efficacy in…
Read More